Anticoagulation therapy using unfractionated heparin at a therapeutic dose for coronavirus disease 2019 patients with severe pneumonia: a retrospective historical control study

AIM: Patients with severe coronavirus disease 2019 (COVID‐19) pneumonia often have complications of coagulopathy and thrombotic phenomena, which lead to high mortality. Whether administering systematic anticoagulant therapy is beneficial remains unclear. We report our experience using systemic antic...

Descripción completa

Detalles Bibliográficos
Autores principales: Takayama, Wataru, Endo, Akira, Otomo, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245744/
https://www.ncbi.nlm.nih.gov/pubmed/34221412
http://dx.doi.org/10.1002/ams2.679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245744/
https://www.ncbi.nlm.nih.gov/pubmed/34221412
http://dx.doi.org/10.1002/ams2.679

Ejemplares similares